Base to Base biotech podcast 44: Treating breast cancer and how a CDMO and immuno-oncology company collaborate
Two-faced nanoparticles help antibiotics treat resistant bacteria
Resolve M Therapeutics exits from stealth
New cancer treatment options through expanding ADC payload spectrum
Base to Base biotech podcast 13: Syngene commits to US market, and Nimbus Therapeutics on computational chemistry
Base to Base biotech podcast 12: CLS boosts drug discovery capabilities and Sitryx – pioneers in immunometabolism
Base to Base biotech podcast 11: Turning cancer into a chronic disease, and a different way to draw blood
Base to Base biotech podcast 10: 3D printing human organs and early detection of ovarian cancer
Base to Base biotech podcast 9: Microbiotica, 1Cell.Ai and Tessellate Bio at AACR
Base to Base biotech podcast 8: ‘Photoshop for proteins’ and improving operations
Base to Base biotech podcast 7: The DSCSA deadline and the first Nanobody
Base to Base biotech podcast 6: Persica Pharmaceuticals and Caszyme